AUC | ADC at baseline | ADC at the ideal time point during chemotherapy | â–³ADC from baseline to the ideal time point during chemotherapy |
---|---|---|---|
Started with taxanes | |||
 Luminal A | 0.556(0.513~ 0.612) | 0.598(0.546~ 0.636) | 0.678(0.598~ 0.749) |
 Luminal B | 0.558(0.525~ 0.623) | 0.602(0.567~ 0.645) | 0.865(0.748~ 0.930) |
 Basal-like | 0.543(0.503~ 0.605) | 0.589(0.558~ 0.649) | 0.723(0.614~ 0.843) |
 HER2-enriched | 0.537(0.521~ 0.619) | 0.593(0.549~ 0.638) | 0.745(0.678~ 0.832) |
Started with anthracyclines | |||
 Luminal A | 0.545(0.521~ 0.598) | 0.587(0.529~ 0.620) | 0.845(0.769~ 0.920) |
 Luminal B | 0.598(0.534~ 0.628) | 0.612(0.528~ 0.656) | 0.723(0.678~ 0.789) |
 Basal-like | 0.612(0.567~ 0.654) | 0.621(0.557~ 0.678) | 0.756(0.698~ 0.845) |
 HER2-enriched | 0.578(0.543~ 0.626) | 0.614(0.551~ 0.636) | 0.734(0.658~ 0.798) |
Started with anthracyclines and taxanes | |||
 Luminal A | 0.534(0.509~ 0.589) | 0.567(0.546~ 0.600) | 0.738(0.645~ 0.798) |
 Luminal B | 0.545(0.502~ 0.620) | 0.587(0.538~ 0.621) | 0.756(0.655~ 0.809) |
 Basal-like | 0.578(0.527~ 0.600) | 0.602(0.567~ 0.629) | 0.879(0.789~ 0.923) |
 HER2-enriched | 0.602(0.526~ 0.645) | 0.623(0.569~ 0.667) | 0.783(0.698~ 0.823) |